BioUtah Announces Early Bird Registration for 2025 Utah Life Sciences Summit with High-Profile Speakers
October 2nd, 2025 4:00 AM
By: Newsworthy Staff
BioUtah has opened early bird registration for the 2025 Utah Life Sciences Summit featuring prominent federal regulators and industry leaders, highlighting Utah's growing $22.6 billion life sciences sector that supports approximately 180,000 jobs.

BioUtah, Utah's trade association dedicated to the life sciences community, has opened Early Bird registration for the 2025 Utah Life Sciences Summit presented by Mayer Brown, with reduced pricing available until October 17. The summit will be held November 12 at the Hilton, Salt Lake City Center, and typically attracts over 500 registrants from across the life sciences spectrum. Register HERE for early bird discounts and view the preliminary agenda HERE.
The event convenes top life sciences leaders, experts, policymakers, and professionals to discuss important industry dynamics, regulatory landscape, market trends, and strategies to promote innovation and advance healthcare. Kelvyn Cullimore, president and CEO of BioUtah, emphasized that the flagship event brings together the best and brightest in the sector for a day of discovery, collaboration, and inspiration, from groundbreaking startups to established industry leaders.
Utah has emerged as one of the nation's fastest-growing life sciences hubs, contributing $22.6 billion to Utah's GDP and supporting approximately 180,000 jobs. The economic and social impact extends throughout the state and beyond, making this summit particularly significant for understanding the sector's trajectory. The speaker lineup includes high-profile federal regulators and industry leaders who will cover thought-provoking topics impacting all segments of Utah's life sciences ecosystem.
Melissa Holyoak, Commissioner of the Federal Trade Commission and a Utahn with expertise in consumer protection, constitutional law, healthcare market competition, and mergers and acquisitions, will provide valuable insights. Michelle Tarver, MD, PhD, Director of FDA's Center for Devices and Radiological Health, will hold a virtual FDA Town Hall discussion about the agency's policy priorities and regulatory initiatives. Peter Marks, MD, former head of the FDA's Center for Biologics Evaluation and Research, brings expertise from overseeing the rapid expansion in FDA-approved cell and gene therapies and playing a key role in establishing Operation Warp Speed. Carter Dredge, Executive Director of the Intermountain Health Institute, rounds out the keynote speakers as a global healthcare thought leader who partners with top thinkers to create novel solutions to complex problems.
The summit will feature dedicated networking programs, including a lunchtime networking session designed to facilitate meaningful professional connections and create space for introductions and conversation with colleagues. The event will also include an impressive lineup of subject-specific tracks covering workforce development, market access, regulatory and quality issues, and legal considerations. Throughout the day, BioUtah will present awards to individuals and companies for their valuable contributions and achievements in the life sciences, recognizing excellence across medical device manufacturing, diagnostics, biopharmaceuticals, and other sectors.
Source Statement
This news article relied primarily on a press release disributed by Reportable. You can read the source press release here,
